SeaStar Medical Holding Corp (ICU)
0.402
+0.06
(+17.72%)
USD |
NASDAQ |
May 16, 16:00
0.4174
+0.02
(+3.83%)
After-Hours: 20:00
SeaStar Medical Enterprise Value: 39.22M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 39.22M |
May 15, 2024 | 34.66M |
May 14, 2024 | 38.13M |
May 13, 2024 | 38.36M |
May 10, 2024 | 39.30M |
May 09, 2024 | 41.40M |
May 08, 2024 | 42.04M |
May 07, 2024 | 44.60M |
May 06, 2024 | 42.25M |
May 03, 2024 | 42.74M |
May 02, 2024 | 46.11M |
May 01, 2024 | 44.01M |
April 30, 2024 | 45.12M |
April 29, 2024 | 47.69M |
April 26, 2024 | 42.10M |
April 25, 2024 | 45.30M |
April 24, 2024 | 47.26M |
April 23, 2024 | 45.85M |
April 22, 2024 | 41.77M |
April 19, 2024 | 39.45M |
April 18, 2024 | 49.63M |
April 17, 2024 | 61.65M |
April 16, 2024 | 62.48M |
April 15, 2024 | 58.88M |
April 12, 2024 | 62.98M |
Date | Value |
---|---|
April 11, 2024 | 63.13M |
April 10, 2024 | 60.94M |
April 09, 2024 | 56.25M |
April 08, 2024 | 58.73M |
April 05, 2024 | 61.51M |
April 04, 2024 | 62.81M |
April 03, 2024 | 64.93M |
April 02, 2024 | 65.58M |
April 01, 2024 | 69.16M |
March 28, 2024 | 56.73M |
March 27, 2024 | 55.04M |
March 26, 2024 | 57.40M |
March 25, 2024 | 59.73M |
March 22, 2024 | 60.91M |
March 21, 2024 | 59.28M |
March 20, 2024 | 61.22M |
March 19, 2024 | 64.28M |
March 18, 2024 | 62.20M |
March 15, 2024 | 64.48M |
March 14, 2024 | 62.33M |
March 13, 2024 | 66.89M |
March 12, 2024 | 74.70M |
March 11, 2024 | 68.18M |
March 08, 2024 | 62.00M |
March 07, 2024 | 60.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.43M
Minimum
Sep 11 2023
142.06M
Maximum
Oct 31 2022
40.49M
Average
35.89M
Median
Enterprise Value Benchmarks
Nuwellis Inc | 3.544M |
Ardelyx Inc | 1.720B |
Adverum Biotechnologies Inc | -22.08M |
Aquestive Therapeutics Inc | 232.19M |
Vir Biotechnology Inc | 201.30M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -9.875M |
Total Expenses (Quarterly) | 2.943M |
EPS Diluted (Quarterly) | -0.2074 |
Earnings Yield | -305.3% |